HAEMONETICS LIMITED
Get an alert when HAEMONETICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-07-12 (in 2mo)
Last made up 2025-06-28
Watchouts
None on the register
Cash
£4M
+2.7% vs 2024
Net assets
£45M
+2.8% vs 2024
Employees
51
+4.1% highest in 4 filed years
Profit before tax
£9M
-82% lowest in 4 filed years
Name history
Renamed 1 time since incorporation
- HAEMONETICS LIMITED 2002-10-01 → present
- HAEMONETICS (U.K.) LIMITED 1975-10-24 → 2002-10-01
Net assets
5-year trend · vs Consumer Discretionary median
Accounts
5-year trend · latest reflected 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Turnover | — | £10,921,822 | £12,403,023 | £18,832,370 | £19,445,305 | |
| Operating profit | — | £430,754 | £1,822,986 | £1,105,672 | £1,838,209 | |
| Profit before tax | — | £59,564,957 | £135,392,806 | £52,337,691 | £9,422,525 | |
| Net profit | — | £59,172,113 | £135,015,743 | £52,020,408 | £8,947,925 | |
| Cash | — | £1,823,176 | £5,593,396 | £4,172,074 | £4,284,171 | |
| Total assets less current liabilities | — | £45,208,151 | £46,771,201 | £43,793,687 | £44,995,951 | |
| Net assets | — | £45,039,949 | £46,485,907 | £43,502,011 | £44,731,536 | |
| Equity | £46,009,107 | £45,039,949 | £46,485,907 | £43,502,011 | £44,731,536 | |
| Average employees | — | 29 | 29 | 49 | 51 | |
| Wages | — | £1,985,332 | £2,160,403 | £3,641,979 | £3,907,526 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | 3.9% | 14.7% | 5.9% | 9.5% | |
| Net margin | — | 541.8% | 1088.6% | 276.2% | 46.0% | |
| Return on capital employed | — | 1.0% | 3.9% | 2.5% | 4.1% | |
| Current ratio | — | — | — | 1.10x | 1.22x | |
| Interest cover | — | 8127.43x | 18229.86x | 212.10x | 90.35x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RDP Newmans LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Group structure
- HAEMONETICS LIMITED · parent
- Haemonetics S.A. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| D'ARECCA, James Christopher | Director | 2022-06-22 | Oct 1970 | American |
| GALLAY, Floriane | Director | 2024-07-16 | Mar 1978 | Swiss |
| GRAHAM, Craig Louis | Director | 2016-10-24 | Sep 1972 | British |
| NARDUZZI, Roberto | Director | 2024-07-16 | Aug 1968 | Italian |
| WATTIN, Nicolas Sven | Director | 2025-07-03 | Jul 1977 | French |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BENTLEY, Brenda | Secretary | — | 2006-10-15 |
| DOCHERTY, Kevin John | Secretary | 2006-09-29 | 2008-06-29 |
| OSHAUGHNESSY, James Shaw | Secretary | 2011-02-11 | 2012-01-03 |
| BARR, John | Director | 1995-01-16 | 1997-11-21 |
| BEE, Daniel John | Director | 2001-07-12 | 2005-04-18 |
| BENTLEY, Brenda | Director | 2002-09-01 | 2006-06-15 |
| BURKE, William Patrick | Director | 2016-10-24 | 2022-06-30 |
| CASANOVA, Alessandro | Director | 2016-10-24 | 2024-08-31 |
| DIEMER, Manfred | Director | 2005-04-27 | 2006-06-16 |
| DOCHERTY, Kevin John | Director | 2006-07-03 | 2007-09-10 |
| DRANSART, Alain | Director | 2000-05-01 | 2001-08-01 |
| EDGAR, Tom | Director | 2006-07-03 | 2007-09-10 |
| GRANVILLE, William | Director | 2000-05-01 | 2002-09-13 |
| LANE, Geoffrey | Director | — | 1998-01-07 |
| LINDOP, Christopher James | Director | 2007-09-10 | 2016-05-25 |
| MANNING, Elizabeth Anne | Director | 2007-09-07 | 2010-11-18 |
| PETERSON, James Leslie | Director | — | 2002-09-13 |
| RYAN, Ronald Joseph | Director | 2002-09-01 | 2007-09-10 |
| TOMOSIVITCH, Christopher | Director | 2007-09-10 | 2013-12-04 |
| URQUHART, David Stewart | Director | 1998-03-05 | 2000-05-11 |
| WEIBEL, Damiano Stuart | Director | 2013-12-04 | 2016-10-24 |
| WHITE, John | Director | — | 1998-01-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haemonetics Corporation | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 170 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-05 | AA | accounts | Accounts with accounts type full | |
| 2025-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-11 | AA | accounts | Accounts with accounts type full | |
| 2024-09-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-29 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-29 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-29 | AA | accounts | Accounts with accounts type full | |
| 2023-06-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-07 | AA | accounts | Accounts with accounts type full | |
| 2022-08-17 | AP01 | officers | Appoint person director company with name date | |
| 2022-08-17 | TM01 | officers | Termination director company with name termination date | |
| 2022-06-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-06-14 | CH01 | officers | Change person director company with change date | |
| 2022-06-14 | CH01 | officers | Change person director company with change date | |
| 2021-12-23 | AA | accounts | Accounts with accounts type full | |
| 2021-06-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-06-18 | AA | accounts | Accounts with accounts type full | |
| 2021-05-05 | PSC05 | persons-with-significant-control | Change to a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
+3.3%
£18,832,370 £19,445,305
highest in 4 filed years
-
Cash
+2.7%
£4,172,074 £4,284,171
-
Net assets
+2.8%
£43,502,011 £44,731,536
-
Employees
+4.1%
49 51
highest in 4 filed years
-
Operating profit
+66.3%
£1,105,672 £1,838,209
highest in 4 filed years
-
Profit before tax
-82%
£52,337,691 £9,422,525
lowest in 4 filed years
-
Wages
+7.3%
£3,641,979 £3,907,526
highest in 4 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers